These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 9356863

  • 21. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [Abstract] [Full Text] [Related]

  • 22. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD.
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [Abstract] [Full Text] [Related]

  • 23. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN, Wang JH, Liu SL, Hung CH, Chen CH, Tung HD, Chen TM, Huang WS, Lee CM, Chen CC, Changchien CS.
    Cancer; 2006 Nov 01; 107(9):2212-22. PubMed ID: 17019738
    [Abstract] [Full Text] [Related]

  • 24. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R.
    Cancer; 1999 May 15; 85(10):2132-7. PubMed ID: 10326690
    [Abstract] [Full Text] [Related]

  • 25. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
    Tanaka T, Inoue K, Hayashi Y, Abe A, Tsukiyama-Kohara K, Nuriya H, Aoki Y, Kawaguchi R, Kubota K, Yoshiba M, Koike M, Tanaka S, Kohara M.
    J Med Virol; 2004 Feb 15; 72(2):223-9. PubMed ID: 14695663
    [Abstract] [Full Text] [Related]

  • 26. Course of viral hepatitis B and combined B and C hepatitis in children treated for neoplastic diseases.
    Kołtan S, Wysocki M, Kołtan A, Swiatkiewicz V, Styczyński J, Debski R, Balcar-Boroń A.
    Med Sci Monit; 2002 Apr 15; 8(4):CR274-9. PubMed ID: 11951070
    [Abstract] [Full Text] [Related]

  • 27. Epidemiological and clinical aspects of liver cirrhosis in adult patients living in Southeastern Anatolia: leading role of HBV in 505 cases.
    Bayan K, Yilmaz S, Tuzun Y, Yildirim Y.
    Hepatogastroenterology; 2007 Dec 15; 54(80):2198-202. PubMed ID: 18265632
    [Abstract] [Full Text] [Related]

  • 28. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep 15; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 29. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers.
    Liaw YF, Tsai SL, Sheen IS, Chao M, Yeh CT, Hsieh SY, Chu CM.
    Am J Gastroenterol; 1998 Mar 15; 93(3):354-9. PubMed ID: 9517639
    [Abstract] [Full Text] [Related]

  • 30. High seroprevalence of hepatitis C virus and dual infection (hepatitis B and C virus) in non-alcoholic chronic liver disease in north India.
    Sood A, Sidhu SS, Midha V, Jyoti D.
    J Assoc Physicians India; 1999 Feb 15; 47(2):205-8. PubMed ID: 10999093
    [Abstract] [Full Text] [Related]

  • 31. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 Feb 15; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

  • 32. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.
    Chu CJ, Lee SD.
    J Gastroenterol Hepatol; 2008 Apr 15; 23(4):512-20. PubMed ID: 18397482
    [Abstract] [Full Text] [Related]

  • 33. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.
    Castellares C, Barreiro P, Martín-Carbonero L, Labarga P, Vispo ME, Casado R, Galindo L, García-Gascó P, García-Samaniego J, Soriano V.
    J Viral Hepat; 2008 Mar 15; 15(3):165-72. PubMed ID: 18233989
    [Abstract] [Full Text] [Related]

  • 34. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, Keles H.
    Ren Fail; 2006 Mar 15; 28(8):729-35. PubMed ID: 17162434
    [Abstract] [Full Text] [Related]

  • 35. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May 15; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 36. [HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study].
    Perret JL, Moussavou-Kombila JB, Delaporte E, Pemba LF, Boguikouma JB, Matton T, Larouze B.
    Gastroenterol Clin Biol; 2002 Feb 15; 26(2):131-5. PubMed ID: 11938063
    [Abstract] [Full Text] [Related]

  • 37. Low prevalence of hepatitis C viral infection in patients with non-alcoholic chronic liver disease in India.
    Sarin SK, Guptan RC, Banerjee K, Khandekar P.
    J Assoc Physicians India; 1996 Apr 15; 44(4):243-5. PubMed ID: 9251393
    [Abstract] [Full Text] [Related]

  • 38. Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia.
    Abe K, Hayakawa E, Sminov AV, Rossina AL, Ding X, Huy TT, Sata T, Uchaikin VF.
    J Clin Virol; 2004 May 15; 30(1):57-61. PubMed ID: 15072755
    [Abstract] [Full Text] [Related]

  • 39. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-Correa MC, DePamphilis J, Torriani FJ, APRICOT Investigators.
    J Med Virol; 2007 Jun 15; 79(6):694-700. PubMed ID: 17457912
    [Abstract] [Full Text] [Related]

  • 40. Prevalence and significance of HCV infection in a consecutive series of patients with HBV antibodies and raised aminotransferases.
    Delle Monache M, Santolamazza M, Marinelli RM, Ricci GL.
    Ital J Gastroenterol; 1991 Jun 15; 23(3):140-1. PubMed ID: 1660329
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.